The chemical class denoted as ZIP-kinase inhibitors encompasses a diverse group of organic compounds characterized by their distinctive molecular structures and their capacity to interact with specific components of the ZIP kinase family. ZIP kinases, or zipper-interacting protein kinases, represent a subset of serine/threonine kinases that exert influence over various cellular processes. The development and refinement of ZIP-kinase inhibitors are grounded in a profound comprehension of the intricate biochemical mechanisms associated with these kinases, which play integral roles in signaling cascades and cellular regulation. These inhibitors are carefully designed through a combination of rational drug design and empirical experimentation. Researchers employ sophisticated techniques to tailor the structural attributes of ZIP-kinase inhibitors, enabling them to precisely bind to specific regions of ZIP kinases or their interacting partners. This selective binding capability enables ZIP-kinase inhibitors to impede the enzymatic activities of ZIP kinases, ultimately modulating the downstream molecular events that these kinases regulate.
The chemical structures of ZIP-kinase inhibitors exhibit notable variability, mirroring the intricate nature of ZIP kinases and their multifaceted interactions within cellular pathways. The design of ZIP-kinase inhibitors is underpinned by an amalgamation of structural biology insights, computational modeling, and in-depth biochemical analyses. By dissecting the molecular interactions involving ZIP kinases, researchers can strategically engineer inhibitors with tailored properties to selectively disrupt ZIP kinase-associated processes. ZIP-kinase inhibitors hold significant potential as indispensable tools for advancing scientific understanding. By perturbing ZIP kinase-mediated pathways, these inhibitors provide researchers with a means to dissect the intricate web of molecular events underlying cellular functions. The development of ZIP-kinase inhibitors is a reflection of the ongoing commitment to unraveling the nuanced roles that ZIP kinases play in cellular signaling and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
STO-609 | 52029-86-4 | sc-507444 | 5 mg | $140.00 | ||
While primarily known as a CaMKK inhibitor, STO-609 has also been shown to inhibit ZIP kinases. It interferes with the interaction between ZIP kinase and its binding partner, enabling researchers to explore ZIP kinase-related processes. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Although primarily known as an AMP-activated protein kinase (AMPK) inhibitor, Compound C has also been reported to inhibit ZIP kinases. Its broader activity against multiple kinases makes it a useful tool for dissecting cellular pathways. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
While primarily known as a checkpoint kinase 1 (Chk1) inhibitor, AZD7762 has been reported to have inhibitory effects on ZIP kinases. Its kinase-targeting profile adds to its potential utility. | ||||||
LDN-214117 | 1627503-67-6 | sc-507451 | 5 mg | $165.00 | ||
LDN-214117 has been identified as a dual inhibitor of multiple kinases, including ZIP kinases. Its effects on kinase signaling offer opportunities to investigate ZIP kinase functions. | ||||||